Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Clene to Present at Upcoming October Conferences
-
Enphase Energy Expands its Support for Grid Services Programs Across the United States
-
Greenridge Exploration Completes Exploration Program on its Carpenter Lake Project
-
StorONE Launches Exciting New Podcast Series on Entrepreneurship, Innovation, and the Future of Data Storage
-
DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24
-
Sacks Parente Golf Inc. Announces Pricing of $732,000 Underwritten Public Offering of Shares of Common Stock
-
WGU Labs Unveils New Research on “Rising Talent”— 24 Million U.S. Adults Stuck in Low-Wage Jobs
-
Asset Entities Signs Pivotal Agreement to Build What Could Become The World’s Largest Digital Fitness Community
-
Dyadic Expands Global Presence with Participation in Key Industry Events
-
Byrna Technologies Reports Fiscal Third Quarter 2024 Results
-
Celebrate National Dessert Day - October 14 With Flavors Food Tours - Savannah
-
Worksport Ltd Announces Tonneau Cover Models for the Rivian R1T, including an Innovative Solar Tonneau Cover
-
Polar Power Completes Installation of UNHCR Nigeria Contract
-
FDH Aero Earns “Best Place to Work in Aviation” Designation
-
Dayforce to Announce Third Quarter 2024 Financial Results on October 30th and Participate in Upcoming Investor Events and Conferences
-
Samba TV Partners with IRIS.TV to Unlock Next-gen Contextual Advertising and Measurement
-
Auron to Present AUTX-703 Preclinical Data 2024 ENA Symposium
-
BriteCore Recognized as an InsurTech 100 Company
-
DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24
-
Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials
-
Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
NobleAI to Address AI Innovation for Sustainable Product Ingredients at Premier Industry Conferences
-
Europe needs €1.5 trillion to make urban mobility sustainable before 2050
-
Bitget Integrates GMCI Indices Enabling Curated-Secured Trading
-
Brookfield Asset Management to Host Third Quarter 2024 Results Conference Call
-
Rail Vision Announces $20 Million Standby Equity Purchase Agreement
-
TC Energy announces upsizing and results of its cash tender offers
-
Ocular Therapeutix™ to Present at October Ophthalmology Meetings
-
ProKidney to Participate in the UBS Virtual Organ Restoration Day
-
Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation
-
Vanqua Bio Announces Positive Interim Results from Phase 1 Clinical Trial of VQ-101, an Orally Administered, Brain-Penetrant, Allosteric Activator of GCase for the Treatment of GBA-Parkinson’s and R
-
BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea
-
BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114
-
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the 36th EORTC-NCI-AACR Symposium
-
Theratechnologies to Present Data at IDWeek 2024 Highlighting Advances in Treatment and Management of Complications in People with HIV
-
Reunion Neuroscience Partners with Seleni Institute on Effective Diagnosis and Treatment of Maternal Mental Health Disorders
-
Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients
-
Chiesi USA Releases 2023 Sustainability Report and Highlights US Community Engagement Strategy Focus Areas
-
Dyne Therapeutics Presents Data at World Muscle Society Congress Highlighting Promise of FORCE™ Platform to Address Underlying Causes of Neuromuscular Diseases
-
ROCKWOOL A/S – transactions in connection with share buy-back programme
-
Alliance Trust PLC - Net Asset Value
-
Howard Hughes Holdings Inc. Announces Dates and Times for 2024 Third Quarter Earnings Release and Conference Call
-
Springbig Launches Innovative MP5 Messaging Feature with Remarkable Beta Test Results
-
CORRECTION: AS Tallinna Sadam operational volumes for 2024 Q3 and 9 months
-
Panavance Therapeutics Provides Update on Phase 1 Clinical Trial of Misetionamide in Pancreatic Cancer at 2024 Visceral Medicine Congress
-
Xypher.io’s Comprehensive Crypto Alert System to Empower Traders with Real-Time Insights
-
Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers
-
Boosty Labs Celebrates 7 Years of Development Leadership
-
Calvetti Ferguson Adds Assurance Partner to Growing Nashville Office
